Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus1

Genome. 2021 Apr;64(4):386-399. doi: 10.1139/gen-2020-0124. Epub 2020 Oct 21.

Abstract

The angiotensin-converting enzyme 2 (ACE2) is the receptor for the three coronaviruses HCoV-NL63, SARS-CoV, and SARS-CoV-2. ACE2 is involved in the regulation of the renin-angiotensin system and blood pressure. ACE2 is also involved in the regulation of several signaling pathways, including integrin signaling. ACE2 expression is regulated transcriptionally and post-transcriptionally. The expression of the gene is regulated by two promoters, with usage varying among tissues. ACE2 expression is greatest in the small intestine, kidney, and heart and detectable in a variety of tissues and cell types. Herein we review the chemical and mechanical signal transduction pathways regulating the expression of the ACE2 gene and the epigenetic/chromatin features of the expressed gene.

Keywords: SARS-CoV-2; angiotensin-converting enzyme 2 (ACE2); enzyme de conversion de l’angiotensine 2 (ACE2); epigenetic; genome organization; histone and DNA modifications; modifications de l’ADN et des histones; organisation du génome; épigénétique.

Publication types

  • Review

MeSH terms

  • Angiotensin-Converting Enzyme 2 / genetics*
  • COVID-19
  • Epigenesis, Genetic*
  • Gene Expression Regulation
  • Humans
  • Promoter Regions, Genetic
  • Protein Processing, Post-Translational
  • Receptors, Virus / genetics*
  • Renin-Angiotensin System
  • SARS-CoV-2
  • Signal Transduction

Substances

  • Receptors, Virus
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2